Retro Biosciences
Retro Biosciences raises $1B Seed
Quick Facts
Retro Biosciences: Seed Funding Round
Retro Biosciences has successfully raised $1B in Seed funding.
Company Overview
Biotech company focused on extending healthy human lifespan by 10 years
Funding Details
The Seed round was led by Sandro Salsano.
Company Information
- Headquarters: San Francisco, CA
- Founded: 2021
- Employees: 80+
- Category: HealthTech
Investment
Retro Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Sandro Salsano: Verified investor in Seed
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
